000147621 001__ 147621
000147621 005__ 20240229123024.0
000147621 0247_ $$2doi$$a10.1001/jamaoncol.2019.3876
000147621 0247_ $$2pmid$$apmid:31725845
000147621 0247_ $$2ISSN$$a2374-2437
000147621 0247_ $$2ISSN$$a2374-2445
000147621 0247_ $$2altmetric$$aaltmetric:70336944
000147621 037__ $$aDKFZ-2019-02612
000147621 041__ $$aeng
000147621 082__ $$a610
000147621 1001_ $$0P:(DE-He78)ef3f7c40c2c68936a43baab29d559371$$aMukama, Trasias$$b0$$eFirst author
000147621 245__ $$aRisk-Adapted Starting Age of Screening for Relatives of Patients With Breast Cancer.
000147621 260__ $$aChicago, Ill.$$bAmerican Medical Association$$c2020
000147621 3367_ $$2DRIVER$$aarticle
000147621 3367_ $$2DataCite$$aOutput Types/Journal article
000147621 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1636970222_5624
000147621 3367_ $$2BibTeX$$aARTICLE
000147621 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000147621 3367_ $$00$$2EndNote$$aJournal Article
000147621 500__ $$aJAMA Oncol. 2020;6(1):68-74#EA:C120#LA:C120#
000147621 520__ $$aBreast cancer screening guidelines acknowledge the need for earlier screening for women at increased risk but provide limited guidance for women with a family history of breast cancer. A risk-adapted starting age of screening for relatives of patients with breast cancer may help supplement current screening guidelines.To identify the risk-adapted starting age of breast cancer screening on the basis of a woman's detailed family history.This nationwide cohort study analyzed data recorded in the Swedish family-cancer data sets. All women born from 1932 onward and with at least 1 known first-degree relative (FDR) were included (N = 5 099 172). Data from January 1, 1958, to December 31, 2015, were collected. Data were analyzed from October 1, 2017, to March 31, 2019.Family history of breast cancer in FDRs and second-degree relatives (SDRs).Primary invasive breast cancer diagnosis and the age at which women with different constellations of family history attained the risk level at which breast screening is usually recommended.Of the 5 099 172 women included in the study, 118 953 (2.3%) received a diagnosis of primary invasive breast cancer. A total of 102 751 women (86.4%; mean [SD] age at diagnosis, 55.9 [11.1] years) did not have family history of breast cancer in FDRs and SDRs at the time of their diagnosis. Risk-adapted starting age of breast cancer screening varied by number of FDRs and SDRs with breast cancer diagnosis and the age at diagnosis of the FDRs. For example, for screening recommendation at age 50 years for the general population (2.2% 10-year cumulative risk), women with multiple affected FDRs, with the youngest affected relative receiving a diagnosis before age 50 years, reached the benchmark risk level at age 27 years. When the youngest relative received a diagnosis after age 50 years, however, this risk level was attained at age 36 years.This study identifies possible risk-based starting ages for breast cancer screening based on population-based registers. These results may serve as high-quality evidence to supplement current screening guidelines for relatives of patients with breast cancer.
000147621 536__ $$0G:(DE-HGF)POF3-313$$a313 - Cancer risk factors and prevention (POF3-313)$$cPOF3-313$$fPOF III$$x0
000147621 588__ $$aDataset connected to CrossRef, PubMed,
000147621 7001_ $$0P:(DE-He78)e56510c7dedbff7a279ad76dad80eeda$$aKharazmi, Elham$$b1$$eFirst author
000147621 7001_ $$0P:(DE-HGF)0$$aXing, Xu$$b2
000147621 7001_ $$aSundquist, Kristina$$b3
000147621 7001_ $$aSundquist, Jan$$b4
000147621 7001_ $$0P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aBrenner, Hermann$$b5
000147621 7001_ $$0P:(DE-He78)b510b884502b619724039bf33fdae68a$$aFallah, Mahdi$$b6$$eLast author
000147621 773__ $$0PERI:(DE-600)2810928-4$$a10.1001/jamaoncol.2019.3876$$n1$$p68-74$$tJAMA oncology$$v6$$x2374-2437$$y2020
000147621 909CO $$ooai:inrepo02.dkfz.de:147621$$pVDB
000147621 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)ef3f7c40c2c68936a43baab29d559371$$aDeutsches Krebsforschungszentrum$$b0$$kDKFZ
000147621 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)e56510c7dedbff7a279ad76dad80eeda$$aDeutsches Krebsforschungszentrum$$b1$$kDKFZ
000147621 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-HGF)0$$aDeutsches Krebsforschungszentrum$$b2$$kDKFZ
000147621 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)90d5535ff896e70eed81f4a4f6f22ae2$$aDeutsches Krebsforschungszentrum$$b5$$kDKFZ
000147621 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)b510b884502b619724039bf33fdae68a$$aDeutsches Krebsforschungszentrum$$b6$$kDKFZ
000147621 9131_ $$0G:(DE-HGF)POF3-313$$1G:(DE-HGF)POF3-310$$2G:(DE-HGF)POF3-300$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vCancer risk factors and prevention$$x0
000147621 9141_ $$y2020
000147621 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJAMA ONCOL : 2017
000147621 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000147621 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000147621 915__ $$0StatID:(DE-HGF)0310$$2StatID$$aDBCoverage$$bNCBI Molecular Biology Database
000147621 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List
000147621 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000147621 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000147621 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine
000147621 915__ $$0StatID:(DE-HGF)9920$$2StatID$$aIF >= 20$$bJAMA ONCOL : 2017
000147621 9202_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000147621 9201_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000147621 9201_ $$0I:(DE-He78)C070-20160331$$kC070$$lC070 Klinische Epidemiologie und Alternf.$$x1
000147621 9201_ $$0I:(DE-He78)HD01-20160331$$kHD01$$lDKTK HD zentral$$x2
000147621 9200_ $$0I:(DE-He78)C120-20160331$$kC120$$lPräventive Onkologie$$x0
000147621 980__ $$ajournal
000147621 980__ $$aVDB
000147621 980__ $$aI:(DE-He78)C120-20160331
000147621 980__ $$aI:(DE-He78)C070-20160331
000147621 980__ $$aI:(DE-He78)HD01-20160331
000147621 980__ $$aUNRESTRICTED